Annual Accounts Receivable
N/A
31 December 2023
Summary:
Theriva Biologics annual accounts receivable is not available.TOVX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
01 September 2024
Summary:
Theriva Biologics quarterly accounts receivable is not available.TOVX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
TOVX Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time |
Theriva Biologics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2012 | - | $122.00 K(-50.2%) |
June 2012 | - | $245.00 K(-44.3%) |
Mar 2012 | - | $440.00 K(+8.6%) |
Dec 2011 | $405.00 K(+19.5%) | $405.00 K(-18.2%) |
Sept 2011 | - | $494.90 K(+11.3%) |
June 2011 | - | $444.70 K(+3.7%) |
Mar 2011 | - | $428.80 K(+26.5%) |
Dec 2010 | $339.00 K | $339.00 K(-12.5%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $387.40 K(+136.2%) |
June 2010 | - | $164.00 K(+83.7%) |
Mar 2010 | - | $89.30 K(+191.8%) |
Dec 2009 | $30.60 K(>+9900.0%) | $30.60 K(-68.8%) |
Sept 2009 | - | $98.20 K(>+9900.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
June 2001 | - | $761.50 K(-23.8%) |
Dec 2000 | $1.00 M | $1.00 M |
FAQ
- What is the all time high annual accounts receivable for Theriva Biologics?
- What is the all time high quarterly accounts receivable for Theriva Biologics?
What is the all time high annual accounts receivable for Theriva Biologics?
Theriva Biologics all-time high annual accounts receivable is $1.00 M
What is the all time high quarterly accounts receivable for Theriva Biologics?
Theriva Biologics all-time high quarterly accounts receivable is $1.00 M